Mohr Davidow Ventures

News, insights, analysis and data

← Back to Mohr Davidow Ventures profile

Mohr Davidow Ventures related stories

All articles and analysis

  • FLAG Capital collects pledges for latest flurry of funds of funds: UPDATED
    David Toll- 30 October 2013

    FLAG Capital Management LLC filed a flurry of Form Ds with the Securities and Exchange Commission in late October, suggesting it has made good headway on its latest series of funds of funds earmarked for venture capital and buyout funds.

  • VC-backed CardioDx files for IPO
    Iris Dorbian- 14 October 2013

    CardioDx has filed for an IPO. The number of shares to be offered and pricing terms have yet to be decided. CardioDX plans on listing its stock on the NASDAQ under the ticker symbol "CDX." BofA Merrill Lynch and Jefferies LLC will serve as lead underwriters. Headquartered in Palo Alto, Calif., CardioDx is a molecular diagnostics company specializing in cardiovascular genomics. It is backed by Kleiner, Perkins, Caufield & Byers, Mohr Davidow Ventures, TPG Biotech, Intel Capital, Pappas Ventures, DAG Ventures, Asset Management Group, GE Capital, Longitude Capital, JP Morgan, Acadia Woods Partners, Artiman Ventures, Bright Capital, and Temasek.

  • Mohr Davidow is setting the stage to raise a new fund
    Alastair Goldfisher- 11 October 2013

    Mohr Davidow Ventures, which was an investor in newly public Rocket Fuel, is getting close to kicking off fundraising efforts for its 10th venture fund, sister publication Venture Capital Journal reported.

  • Mohr Davidow is setting the stage to raise a new fund
    Alastair Goldfisher- 11 October 2013

    Fund size is unknown, but Silicon Valley firm is gearing up to soon start raising 10th fund

  • Personalis closes $22 mln in Series B financing
    Iris Dorbian- 8 October 2013

    Personalis has raised $22 million in Series B financing. Abingworth was the lead investor with participation from Lightspeed Venture Partners, Mohr Davidow Ventures and Wellington Shields & Co. Based in Menlo Park, Calif., Personalis is a provider of advanced medical exome and genome sequencing.

  • Third annual VCJ conference is here!
    Alastair Goldfisher- 1 October 2013

    Editor’s letter from Alastair Goldfisher

  • FireEye's debut signals red hot interest in cybersecurity
    Staff Writer- 1 October 2013

    Venture firms Sequoia Capital, MDV and Norwest stand to benefit most from FireEye and Rocket Fuel IPOs

  • Student entrepreneurs: You can win a free ticket to our VC conference -- Updated
    Lawrence Aragon- 24 September 2013

    We want help five students working on startups by getting them in front of venture capitalists at our Venture Alpha West conference in Half Moon Bay, Calif., on Oct. 8-9. Send us a 300-word essay explaining why your startup is awesome. The five winners will get free passes to Venture Alpha West.

  • Sequoia, Mohr Davidow, Norwest Benefit From FireEye and Rocket Fuel IPOs
    Mark Boslet- 23 September 2013

    IPOs from FireEye and Rocket Fuel debuted to, well, a combination of fire and fuel on Friday, finishing their first day of trading with 80% and 89.7% share price rises, respectively.

  • Sequoia, Mohr Davidow, Norwest benefit from FireEye and Rocket Fuel IPOs
    Mark Boslet- 20 September 2013

    Mohr Davidow’s Rocket Fuel position worth $629 million, Sequoia’s FireEye holdings total $778 million